Internet Support for Cancer Patients (WebChoice)

This study has been completed.
Sponsor:
Collaborator:
Norwegian Cancer Society
Information provided by (Responsible Party):
Cornelia Ruland, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT00710658
First received: July 3, 2008
Last updated: May 22, 2013
Last verified: May 2013

July 3, 2008
May 22, 2013
May 2006
August 2008   (final data collection date for primary outcome measure)
  • Symptom distress [ Time Frame: prospective, one year, repeated measures ] [ Designated as safety issue: No ]
  • Quality of life [ Time Frame: prospective, one year, repeated measures ] [ Designated as safety issue: No ]
  • Depression [ Time Frame: prospective, one year, repeated measures ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00710658 on ClinicalTrials.gov Archive Site
  • Self-efficacy [ Time Frame: prospective, one year, repeated measures ] [ Designated as safety issue: No ]
  • Social support [ Time Frame: prospective, one year, repeated measures ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Internet Support for Cancer Patients
A Randomized Clincial Trial to Evaluate the Effects of an Internett-based Support System for Cancer Patients on Symptom Distress, Depression, and Quality of Life.

Cancer patients often experience multiple physical, functional and psychosocial symptoms, but have limited support while being at home between treatments and during rehabilitation. WebChoice is a novel Internet support system that extends traditional health services into patients' homes. The system allows patients to monitor symptoms over time, and provides access to evidence-based self-management options tailored to their reported symptoms as well as a communication area where patients can ask questions to a clinical nurse specialist in cancer care and exchange experiences with other cancer patients.

This randomized clinical trial:

  1. Tests the effects of WebChoice on primary outcomes of symptom distress, quality of life, depression and health service use, and secondary outcomes of self-efficacy, social support . We will also analyze:
  2. Relationships between primary and secondary outcomes;
  3. How patients' symptom distress varies over time;
  4. Patients' preferences for participation in decision making about symptom management
  5. How patients use WebChoice, such as frequency of use, duration, most used components;
  6. How patients' experience WebChoice's usefulness and ease of use;
  7. Patterns and content of patients' communication with the cancer nurse and other patients.

325 cancer patients (189 breast cancer and 136 prostate cancer patients) were recruited from throughout Norway through advertisements and invitation letters and the Norwegian Cancer Registry. Patients were randomly assigned to WebChoice or the control group that received usual care. Patients are being followed with 5 repeated measures over 12 months. Data are being collected through questionnaires, from system logs, and from interviews that were conducted in subset of experimental group patients. The primary hypothesis will be tested with Repeated Measures ANCOVA techniques. The other research questions will be answered using various inferential and descriptive techniques and through content analysis of messages and transcripts of patient interviews. This study can make a significant contribution to reduce unnecessary suffering and improve the quality of life for a large group of cancer patients.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
  • Cancer
  • Breast Cancer
  • Prostate Cancer
Behavioral: WebChoice

Patients in the experimental group had over the study period access to the Internet support system WebChoice that allowed them to monitor symptoms over time, and provided access to evidence-based self-management options tailored to their reported symptoms as well as a communication area where patients could ask questions to a clinical nurse specialist in cancer care and exchange experiences with other cancer patients.

Patients in the control group received usual care

Other Name: Internet support
  • Experimental: 1
    Patients had access to the Internet support system WebChoice that allowed them to monitor symptoms over time, and provided access to evidence-based self-management options tailored to their reported symptoms as well as to a communication area where patients could ask questions to a clinical nurse specialist in cancer care and exchange experiences with other cancer patients.
    Intervention: Behavioral: WebChoice
  • No Intervention: 2
    The control group receiving usual care

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
325
November 2008
August 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Above 18 years
  • Starting or currently undergoing treatment for breast or prostate cancer
  • Internet access at home

Exclusion Criteria:

  • Patients who had received radiation on the brain as this may have affected their abilities to reliably report their symptoms.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT00710658
NCS 06067/001
No
Cornelia Ruland, Oslo University Hospital
Oslo University Hospital
Norwegian Cancer Society
Principal Investigator: Cornelia M Ruland, PhD Rikshospitalet-Radiumhospitalet
Oslo University Hospital
May 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP